|
DDX42 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.953200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.783100E-03 |
| Normal-vs-Stage2 |
1.979990E-01 |
| Normal-vs-Stage3 |
3.169200E-04 |
| Normal-vs-Stage4 |
1.357300E-03 |
| Stage1-vs-Stage2 |
5.031200E-01 |
| Stage1-vs-Stage3 |
2.232800E-01 |
| Stage1-vs-Stage4 |
3.402000E-01 |
| Stage2-vs-Stage3 |
1.522960E-01 |
| Stage2-vs-Stage4 |
2.387400E-01 |
| Stage3-vs-Stage4 |
8.779800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.235500E-04 |
| Normal-vs-AfricanAmerican |
1.752420E-01 |
| Normal-vs-Asian |
3.995800E-01 |
| Caucasian-vs-AfricanAmerican |
4.564600E-01 |
| Caucasian-vs-Asian |
7.594300E-02 |
| AfricanAmerican-vs-Asian |
5.940000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.558900E-03 |
| Normal-vs-Female |
5.793600E-04 |
| Male-vs-Female |
6.130000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.382800E-03 |
| Normal-vs-Age(41-60Yrs) |
9.597100E-03 |
| Normal-vs-Age(61-80Yrs) |
5.992700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.136550E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.284800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.450600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.500400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.536800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.361200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.140200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.562300E-04 |
| Classical-VS-Follicular |
1.884390E-03 |
| Classical-VS-Other |
3.530400E-01 |
| Classical-VS-Normal |
1.277380E-01 |
| Tall-VS-Follicular |
4.932400E-01 |
| Tall-VS-Other |
4.545400E-01 |
| Tall-VS-Normal |
2.40549999999118E-05 |
| Follicular-VS-Other |
7.745400E-01 |
| Follicular-VS-Normal |
1.840700E-04 |
| Other-VS-Normal |
1.148610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.264660E-03 |
| Normal-vs-N1 |
5.016500E-04 |
| N0-vs-N1 |
3.401400E-01 |
|
|
